Drugs / arasertaconazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01144286 | Jun 2010 → Mar 2011 | vulvovaginal candidiasis | Ferrer Internacional S.A. | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | arasertaconazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01144286 ↗ |
| Known as | Arasertaconazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1410877 ↗ |
| Modality | Small molecule | — CHEMBL1410877 ↗ |
| Route | Other | “three different doses of arasertaconazole nitrate (150 mg, 300 mg or 600 mg, pessaries)” NCT01144286 ↗ |